Last reviewed · How we verify
NCT05284903
Hearing Aid Performance Study for Different Spatial Configurations
NA trial testing Beamformer Benefit: Speech intelligibility and Listening effort in Hearing Loss in 44 participants. Completed in 5 July 2022.
5 July 2022
Quick facts
| Lead sponsor | Sonova AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | other |
| Enrollment | 44 |
| Start date | 21 March 2022 |
| Primary completion | 5 July 2022 |
| Estimated completion | 5 July 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Beamformer Benefit: Speech intelligibility and Listening effort
- Speech Enhancer benefit: Speech intelligibility, Listening effort and Subjective Speech intelligibility
- Hearing aid benefit: Speech intelligibility in noise (unaided vs aided condition)
- Hearing aid benefit: Speech intelligibility in noise (aided condition)
Conditions studied
- Hearing Loss — all drugs for Hearing Loss →
Sponsor
Sonova AG — full company profile →
Who can join
18 and older, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical investigation will extend the evaluation of perception of speech in different listening environments with hearing aids available on the market (from Phonak). The clinical investigation is divided in three parts addressing different challenges met by hearing aid users.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05284903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss
Currently open trials in the same condition.
- NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III · Phase 1 · recruiting
- NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
- NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting
Other Sonova AG trials
Trials by the same sponsor.
- NCT07526428 — Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment · NA · enrolling by invitation
- NCT07501312 — Remote Microphone Performance Comparison in Adults With Hearing Loss · NA · enrolling by invitation
- NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
- NCT06957730 — A Comparison of Hearing Aid Noise Programs on Speech Intelligibility · NA · completed
- NCT06746038 — Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05284903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sonova AG
- Last refreshed: 6 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05284903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing